Published Date: 02 Mar 2023
When the arteries supplying blood to the stomach and liver swell and burst, it is an emergency in which 50% of patients die before reaching the hospital. This "silent killer" situation, know...
Read Full NewsIZAR-1: Sonelokimab Meets Phase 3 End Points for PsA
Two-season real-world data show Arexvy reduces RSV-related MACE and COPD and asthma exacerbations in adults 60 and older, Ann Falsey, MD, says.
Guy Brusselle, MD, PhD, says that 64% of dupilumab-treated patients met composite asthma clinical remission criteria at week 24 versus 40.5% with omalizumab.
What The FDA Psychedelic Hearing Means for Psychiatrists
A new phase 4 trial, OCTAGON, will test a rapid, predefined corticosteroid-tapering schedule in patients with generalized myasthenia gravis treated with ravulizumab.
A phase 4 study is evaluating whether adults with chronic inflammatory demyelinating polyneuropathy can transition from intravenous immunoglobulin to subcutaneous efgartigimod PH20 without first experiencing disease worsening.
Real-world 12‑month results from WeSMA, a phase 4 study, showed that oral risdiplam is well tolerated in adults with SMA, with stable motor function and consistent safety findings.
1.
Decoding calcifications in breast cancer: Towards personalized medicine
2.
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
3.
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.
4.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
5.
Researchers study effects of cannabis on sedation, cancer treatment symptoms
1.
Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics
2.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
3.
Oncologic Emergencies: Diagnosis and Treatment
4.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
5.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
5.
Understanding Common Causes of Abnormal Blood Counts
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation